All ingredients in Breast Gain Plus™ meet FDA guidelines and are considered generally safe and effective.

The US Food and Drug Administration (FDA) does not approve or disapprove of any kind of dietary supplements. Although, RUMO PLUS™ is within all FDA rules and regulations for dietary supplements. RUMO PLUS™ is also approved by the FDCA (Food and Drug Control Administration of India). For more information, check out the FDCA's website.

Our breast enhancement pill contains only natural herbal ingredients: Fenugreek Seed Extract, Black Cohosh Root Extract, Saw Palmetto Berry, Dong Quai Roo, Fennel Seed, L-Tyrosine, Pacific Kelp, Damiana Leaft, Mother Wort Herb, Mexican Wild Yam Root, Oat Grass, Blessed Thistle Herb, Hops Flower. Other Ingredients: Gelatin and Artificial Colors. You can read more on ingredients page.

You may Breast Gain Plus™ order by credit card, check or money order. We accept payment online, by fax and by mail.

Absolutely, taking Breast Gain Plus™ after having breast implants typically result in filling of the tissue around the implants giving a fuller and more natural look.

Breast Gain Plus is manufactured under strict FDA guidelines. All ingredients in Breast Gain Plus meet FDA guidelines and are considered generally safe and effective.

The Food & Drug Administration does not have an approval process for any nutritional supplements, only perscription medications. However, Flexcin is manufactured in a FDA inspected and approved facility.

The U. S. Congress passed the Dietary Supplement Health and Education Act (DSHEA) of 1994 which spells out the regulations as they apply to dietary supplements.

The price of the test is $200, including shipping costs. Payment can be made by any major credit card by the individual or by the ordering physician or clinic, by including the card details on the test request form. Samples submitted anonymously must be accompanied by a valid credit card number from the respective doctor or affiliated health care institution.

Currently, non-prescription nutritional supplements do not require FDA approval. However, BioVitale's Digestive Enzyme Complex is manufactured in a FDA monitored and approved facility under the highest quality control standards.

The anti-pathogenic and germicidal properties of the silver oxide in Safe Lips has been tested by 14 reputable and independent Contract Research Organizations (CROs). Countless individuals have contacted us with their very positive feedback, declaring the Safe Lips was the major factor in returning them to healthy skin. Furthermore, we have a very liberal return policy where customer satisfaction is 100% guaranteed, and yet we have experienced very few returns.

Yes, most of our users of the Quit Smoking Support System reported that they managed to stop smoking and no longer experienced cravings or withdrawal symptoms. Few smoking cessation products out there can make such similar claims in efficacy, ease, and successfulness.

ECP is approved by the FDA for the treatment of Angina and Congestive Heart Failure. It has undergone rigorous clinical trials at leading universities around the country and ECP has been the subject of scientific studies published in leading medical journals.

The US Food and Drug Administration (FDA) does not approve or disapprove of any kind of dietary supplements, such as Revivol ™, since it is not within their responsibility. The FDA only approves or disapproves of pharmaceutical drugs, which Revivol™ is not.

ZymaDerm is 'FDA Compliant' and conforms to the standards of the Homeopathic Pharacopeia of the United States (HPUS), a compendium recognized as both official and authoritative by the FDA. Each of the ingredients in ZymaDerm is stated in the Pharmacopeia to be useful as an aid in the treatment of skin rash conditions. If a drug-free agent is listed in the HPUS for treating certain conditions, a product containing that agent may be marketed for those conditions without specific FDA approval.

Our entire service has been scientifically reviewed for safety and effectiveness by the U.S. Food and Drug Administration (FDA). FDA granted Home Access Health nationwide clearance to market its service on April 28, 1999. The Home Access at-home telemedicine Hepatitis C counseling and testing service is the ONLY such service available in the United States approved by the U.S. Food and Drug Administration.